Total Payments
$102,416
2024 Payments
$102.05
Companies
27
Transactions
314
Medicare Patients
581
Medicare Billing
$44,323
Payment Breakdown by Category
Other$77,371 (75.5%)
Consulting$14,155 (13.8%)
Travel$5,392 (5.3%)
Food & Beverage$5,153 (5.0%)
Education$344.74 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $76,371 | 40 | 74.6% |
| Consulting Fee | $14,155 | 7 | 13.8% |
| Travel and Lodging | $5,392 | 33 | 5.3% |
| Food and Beverage | $5,153 | 225 | 5.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,000 | 1 | 1.0% |
| Education | $344.74 | 8 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $41,495 | 80 | $0 (2020) |
| GENZYME CORPORATION | $19,819 | 42 | $0 (2021) |
| EMD Serono, Inc. | $18,747 | 47 | $0 (2024) |
| Acorda Therapeutics, Inc | $8,638 | 12 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $8,550 | 45 | $0 (2019) |
| Mallinckrodt LLC | $2,725 | 9 | $0 (2017) |
| LivaNova USA, Inc. | $1,159 | 7 | $0 (2019) |
| Genentech USA, Inc. | $268.54 | 12 | $0 (2018) |
| Supernus Pharmaceuticals, Inc. | $208.81 | 13 | $0 (2018) |
| Allergan Inc. | $156.64 | 9 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $102.05 | 1 | EMD Serono, Inc. ($102.05) |
| 2023 | $70.90 | 1 | EMD Serono, Inc. ($70.90) |
| 2022 | $341.33 | 4 | EMD Serono, Inc. ($341.33) |
| 2021 | $226.32 | 5 | EMD Serono, Inc. ($208.74) |
| 2020 | $3,540 | 3 | Biogen, Inc. ($2,880) |
| 2019 | $16,929 | 26 | Biogen, Inc. ($11,350) |
| 2018 | $27,854 | 58 | Biogen, Inc. ($11,657) |
| 2017 | $53,353 | 216 | Biogen, Inc. ($15,608) |
All Payment Transactions
314 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $102.05 | General |
| 03/01/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $70.90 | General |
| Category: Neurology | ||||||
| 10/26/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $163.05 | General |
| 09/16/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $39.64 | General |
| 01/27/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $99.50 | General |
| 01/14/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $39.14 | General |
| 12/08/2021 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $95.11 | General |
| 12/08/2021 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Neurology | ||||||
| 11/11/2021 | EMD Serono, Inc. | — | Food and Beverage | In-kind items and services | $5.26 | General |
| 11/10/2021 | EMD Serono, Inc. | — | Food and Beverage | In-kind items and services | $97.52 | General |
| 07/07/2021 | EMD Serono, Inc. | — | Food and Beverage | In-kind items and services | $10.85 | General |
| 08/19/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $660.00 | General |
| Category: Neurology | ||||||
| 05/06/2020 | Biogen, Inc. | TECFIDERA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: NEUROLOGY | ||||||
| 01/28/2020 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| 11/06/2019 | Biogen, Inc. | TECFIDERA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2019 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $110.50 | General |
| 09/13/2019 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: NEUROLOGY | ||||||
| 09/12/2019 | Biogen, Inc. | TECFIDERA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,880.00 | General |
| Category: NEUROLOGY | ||||||
| 09/12/2019 | Biogen, Inc. | TECFIDERA (Drug) | Travel and Lodging | Cash or cash equivalent | $325.91 | General |
| Category: NEUROLOGY | ||||||
| 09/12/2019 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | Cash or cash equivalent | $42.85 | General |
| Category: NEUROLOGY | ||||||
| 05/21/2019 | Biogen, Inc. | TECFIDERA (Drug) | Travel and Lodging | Cash or cash equivalent | $56.26 | General |
| Category: NEUROLOGY | ||||||
| 05/21/2019 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | Cash or cash equivalent | $42.85 | General |
| Category: NEUROLOGY | ||||||
| 05/21/2019 | Biogen, Inc. | TECFIDERA (Drug) | Travel and Lodging | Cash or cash equivalent | $6.50 | General |
| Category: NEUROLOGY | ||||||
| 05/14/2019 | Biogen, Inc. | TECFIDERA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,880.00 | General |
| Category: NEUROLOGY | ||||||
| 03/13/2019 | Biogen, Inc. | TECFIDERA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 26 | 26 | $12,740 | $2,637 |
| 2022 | 5 | 89 | 94 | $31,988 | $7,939 |
| 2021 | 4 | 82 | 83 | $36,915 | $8,828 |
| 2020 | 11 | 384 | 448 | $85,524 | $24,920 |
Total Patients
581
Total Services
651
Medicare Billing
$44,323
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $12,740 | $2,637 | 20.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 35 | 35 | $11,727 | $2,755 | 23.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $8,861 | $2,306 | 26.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 14 | $4,144 | $1,094 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $4,181 | $968.00 | 23.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 15 | $3,075 | $816.45 | 26.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 22 | 22 | $12,886 | $3,166 | 24.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $11,444 | $2,545 | 22.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 19 | $6,607 | $1,716 | 26.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 18 | 18 | $5,978 | $1,401 | 23.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 68 | 78 | $23,378 | $4,706 | 20.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 62 | 71 | $7,888 | $4,374 | 55.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 66 | 71 | $15,077 | $3,316 | 22.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 17 | $5,342 | $2,684 | 50.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 51 | 58 | $4,325 | $2,155 | 49.8% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2020 | 23 | 25 | $7,521 | $1,919 | 25.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 12 | 24 | $6,564 | $1,828 | 27.8% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2020 | 14 | 17 | $5,679 | $1,312 | 23.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 20 | 36 | $3,653 | $1,248 | 34.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 31 | $4,317 | $1,216 | 28.2% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 20 | 20 | $1,781 | $162.88 | 9.1% |
About Dr. Mitchell Ross, MD
Dr. Mitchell Ross, MD is a Neurology healthcare provider based in Auburn, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073503660.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Ross, MD has received a total of $102,416 in payments from pharmaceutical and medical device companies, with $102.05 received in 2024. These payments were reported across 314 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($76,371).
As a Medicare-enrolled provider, Ross has provided services to 581 Medicare beneficiaries, totaling 651 services with total Medicare billing of $44,323. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Electrodiagnostic Medicine
- Location Auburn, ME
- Active Since 10/25/2005
- Last Updated 03/20/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1073503660
Products in Payments
- TECFIDERA (Drug) $35,426
- Rebif (Biological) $17,332
- AUBAGIO (Drug) $10,688
- LEMTRADA (Drug) $9,131
- AMPYRA (Drug) $8,638
- COPAXONE (Drug) $8,316
- TYSABRI (Biological) $4,863
- ACTHAR (Biological) $2,725
- VNS Therapy (Device) $1,192
- Mavenclad (Drug) $660.00
- OCREVUS (Biological) $262.00
- TROKENDI XR (Drug) $169.84
- NAMZARIC (Drug) $130.12
- ZINBRYTA (Biological) $125.00
- AUSTEDO (Drug) $86.65
- MAVENCLAD (Drug) $70.90
- APTIOM (Drug) $70.07
- Zinbryta (Biological) $62.59
- NUPLAZID (Drug) $54.81
- XEOMIN (Biological) $48.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Auburn
Jianxin Ma, M.d, M.D
Neurology — Payments: $13,709
Neurology $13,709
Kanwardeep Grewal, M.d, M.D
Neurology — Payments: $7,099
Neurology $7,099
Ijaz Rashid, M.d, M.D
Neurology — Payments: $6,515
Neurology $6,515
Gregory Dardas, Md, MD
Neurology — Payments: $5,972
Neurology $5,972
Dr. Minna Hancock, D.o, D.O
Neurology — Payments: $5,064
Neurology $5,064
Dr. Paul Fu, M.d, M.D
Neurology — Payments: $4,489
Neurology $4,489